Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Immunol ; 166(2): 982-8, 2001 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-11145676

RESUMO

LPS is the major active agent in the pathogenesis of Gram-negative septic shock. In this report we have studied the influence of concurrent viral infection on the outcome of LPS-induced shock. We find that infection with vesicular stomatitis virus sensitizes mice to LPS at an early time point following infection. Treatment of mice with the chemical IFN inducer, polyinosinic:polycytidylic acid, has a similar effect. This hypersensitivity to LPS correlated with hyperproduction of TNF-alpha in vivo. The cellular and molecular mechanisms underlying this phenomenon were investigated using Ab-depleted and gene-targeted mice. Our results revealed that while NK cell depletion and elimination of IFN-gamma partially protected against the sensitizing effects of vesicular stomatitis virus and polyinosinic:polycytidylic acid, the most striking effect was observed in IFN-alphabetaR-deficient mice. Thus hyperproduction of TNF-alpha was completely abrogated in IFN-alphabetaR-deficient mice, indicating that the principal mechanism underlying rapid virus-induced sensitization to LPS is an IFN-alphabeta-mediated priming of mice for an augmented production of TNF-alpha in response to LPS. This conclusion was further supported by the finding that pretreatment of mice with rIFN-alphabeta mimicked the effect of viral infection. In conclusion, our results reveal a previously unrecognized proinflammatory effect of IFN-alphabeta and point to a new pathway through which viral infection may influence the outcome of concurrent bacterial infection.


Assuntos
Interferon Tipo I/fisiologia , Lipopolissacarídeos/toxicidade , Infecções por Rhabdoviridae/imunologia , Choque Séptico/imunologia , Vírus da Estomatite Vesicular Indiana/imunologia , Animais , Linfócitos B/imunologia , Suscetibilidade a Doenças , Feminino , Humanos , Injeções Intraperitoneais , Indutores de Interferon/administração & dosagem , Interferon Tipo I/administração & dosagem , Interferon gama/fisiologia , Células Matadoras Naturais/imunologia , Coriomeningite Linfocítica/imunologia , Coriomeningite Linfocítica/microbiologia , Coriomeningite Linfocítica/mortalidade , Vírus da Coriomeningite Linfocítica/imunologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Camundongos Nus , Poli I-C/administração & dosagem , Proteínas Recombinantes , Infecções por Rhabdoviridae/microbiologia , Infecções por Rhabdoviridae/mortalidade , Choque Séptico/mortalidade , Choque Séptico/virologia , Linfócitos T/imunologia , Fatores de Tempo , Fator de Necrose Tumoral alfa/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA